The Company estimates that its revenues for 2007 will range from US$128 million to US$132 million.
Following the earnings announcement, WuXi PharmaTech's senior management will host a conference call at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Hong Kong) on Thursday, September 6, 2007 to discuss its 2007 second quarter financial results and recent business activities. The conference call may be accessed by calling (US) +1 718 354 1157 / (UK) +44 (0)20 7138 0815 / (HK) +852 3002 1616. A telephone replay will be available shortly after the call until October 5, 2007 at (US) +1 718 354 1112/ (UK) +44 (0)20 7806 1970 / (HK) +852 3002 1607, Passcode: 1468987.
A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at http://www.wuxipharmatech.com .
About WuXi PharmaTech
Founded in 2000, Shanghai-based WuXi PharmaTech is the leading
China-based pharmaceutical and biotechnology R&D outsourcing company. As a
research- driven and customer-focused company, WuXi PharmaTech provides
pharmaceutical and biotechnology companies a broad and integrated portfolio
of laboratory and research manufacturing services throughout the drug
discovery and development process. WuXi PharmaTech's services are designed
to assist its global partners in shortening the cycle and lowering the cost
of drug discovery and development by providing cost-effective and efficient
outsourcing solutions that save its customers both time and money. Its
operations are grouped into two segments: laboratory services, consisting
of discovery chemistry, service biology, analytical, pharmaceutical
development and process development services, and research manufacturing,
focusing on manufacturing of advanced int
|SOURCE WuXi PharmaTech (Cayman) Inc.|
Copyright©2007 PR Newswire.
All rights reserved